Clinical Trial Update: CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission [Phase 3]

View source ↗

Summary

A completed Phase 3 trial (CORE) evaluating OPC-6535 in combination with Asacol for maintaining remission in ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Asacol (mesalamine)
• OPC-6535

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED